Live search
TopFind is fetching the latest matches for your search.
We reviewed 595 live results for infusion therapy and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Hospital Services and Immunology.
Source: National University Hospital (NUH)
Description
Specialized intravenous immunoglobulin (IVIG) infusion service using Flebogamma DIF (5% and 10%) as part of the hospital's drug formulary. The treatment is administered by trained healthcare professionals for patients with immunodeficiency or immunomodulatory requirements.
Best for
tertiary care patients, specialized IVIG infusion, hospital formulary drug access and immunological disorders
Rating
Source: Samitivej Hospital
Description
A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy.
Best for
intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care
Rating
Source: Roche
Description
Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage.
Best for
Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access
Rating
| Compare | Flebogamma DIF Infusion Therapy | Infliximab Infusion | Actemra Intravenous (IV) Infusion |
|---|---|---|---|
| Source | National University Hospital (NUH) | Samitivej Hospital | Roche |
| Description | Specialized intravenous immunoglobulin (IVIG) infusion service using Flebogamma DIF (5% and 10%) as part of the hospital's drug formulary. The treatment is administered by trained healthcare professionals for patients with immunodeficiency or immunomodulatory requirements. | A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy. | Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage. |
| Best for | tertiary care patients, specialized IVIG infusion, hospital formulary drug access and immunological disorders | intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care | Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Flebogamma DIF Infusion Therapy from National University Hospital (NUH)."
I picked this because One of the major public healthcare institutions in Singapore with both concentrations of Flebogamma DIF listed in its official formulary.